Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide vs Topiramate in Migraine
NCT06347497Phase 3Completed
- Sponsor
- Kafrelsheikh University
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zonisamide in migraine, sponsored by Kafrelsheikh University. Started Apr 2024; status: completed.
02
Drugs
zonisamide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06347497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06347497.